Vontobel Holding Ltd. Has $621,000 Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Vontobel Holding Ltd. raised its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,893 shares of the exchange traded fund’s stock after buying an additional 351 shares during the period. Vontobel Holding Ltd.’s holdings in SPDR S&P Biotech ETF were worth $621,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Healthcare of Ontario Pension Plan Trust Fund increased its position in shares of SPDR S&P Biotech ETF by 198.6% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after purchasing an additional 6,138,000 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd purchased a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at $141,284,000. Assetmark Inc. increased its position in shares of SPDR S&P Biotech ETF by 72,653.0% during the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock valued at $58,223,000 after purchasing an additional 588,489 shares during the last quarter. Sivik Global Healthcare LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at $29,640,000. Finally, Mirae Asset Securities USA Inc. increased its position in shares of SPDR S&P Biotech ETF by 50.0% during the 3rd quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock valued at $88,920,000 after purchasing an additional 300,000 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI opened at $92.53 on Thursday. The business has a 50-day moving average of $91.42 and a 200 day moving average of $96.00. SPDR S&P Biotech ETF has a fifty-two week low of $81.14 and a fifty-two week high of $105.47. The firm has a market cap of $7.05 billion, a P/E ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.